Fabrizio Di Costanzo

Medical Oncology resident - PhD student

[International Urology Cancer Summit @urologysummit]

Join the #IUCS Chairs, Faculty, Ambassadors and the whole growing community 📣

#IUCS26 Programme is online & Registrations are open!

📍 Guildford or Virtual
🔗 Info: https://t.co/7VP0Zo8gqy
🎟 FREE: https://t.co/2tD5p9i4pd

#oncology #UroOnc #ProstateCancer #BladderCancer #RCC

[pas_rescigno @PasRescigno]

Always the best discussion from @Ecastromarcos

[pas_rescigno @PasRescigno]

Is single agent TKI an option for selected mRCC patients? Please listen to this podcast and share your opinion #EAU #EMUC25 @gbanna74 @RebuzziSara @DrYukselUrun what’s your though?

https://t.co/t2qO2sOwie

[Giuseppe Procopio @g_procopio_]

A network meta-analysis shows that treatment choice in #mHSPC should be guided by disease volume. #ClinicalResearch #Genitourinary #ProstateCancer #Oncology #MetaAnalysis

More info here:
https://t.co/xYIEMlvTrG

[Enrique Grande @drenriquegrande]

The soul of Oncology, the spirit of science: the @aron_project. Thanks @myesmo for allowing us to meet at #ESMO25 Not easy to see a group with more scientific production in the field of GU. @OncoAlert @fsabino_onco @SoaresAndrey @fmassari79 @MatteoSantoniMD @raymanneh @JaviMolinaC @giannatempopatr @dralvaropinto @KarineTrindadeM

[pas_rescigno @PasRescigno]

Proud of my team #Newcastle their work mentioned @ESMO25 by Dr Enting @FabrizioDiCost on real evidence of Abi+RT in locally advanced PCa

[pas_rescigno @PasRescigno]

The #IUCS25 came to an end!I want to congratulate @gbanna74 for the amazing organization, more importantly for his friendship!Great talks @neerajaiims @AlbigesL @PGrivasMDPhD @Ecastromarcos @alison_tree @drenriquegrande @montypal @RebuzziSara @DrYukselUrun and many others 🙌

[International Urology Cancer Summit @urologysummit]

Oral at #IUCS25:
#Real-world data: most high-risk pts on adjuvant abiraterone/P + ADT achieve ultralow PSA within 12 mo - even if stopping early. Questions the need for fixed 24-mo therapy & supports response-adapted approaches.

@FabrizioDiCost @OncoAlert

#GUCancers #STAMPEDE

[International Urology Cancer Summit @urologysummit]

Poster at #IUCS25

#mCRPC treatment: Abi-Ola shows real-world feasibility. #ProstateCancer

@mona_hssn @FabrizioDiCost @gbanna74
@OncoAlert

#urology #cancer

[ONCOassist® | The go-to oncology app @ONCOassist]

🎥 New on #OncologyBytes from #IUCS2024
Dr. Fabrizio Di Costanzo: Can TK1 track treatment response in mHSPC?
📉 Early data shows TK1 & PSA decline together in most patients.
📺 Watch: https://t.co/9MW8aPT5yY
🌐 Learn more at: https://t.co/EMQ9jdDkzk
#ProstateCancer #Biomarkers #mHSPC #TK1 #Oncoassist #CancerCare #Oncoalert @FabrizioDiCost @urologysummit @gbanna74

[pas_rescigno @PasRescigno]

Great sessions at #EMUC24 with @Ecastromarcos @alison_tree @AOmlin @GGiannarini @F_Sanguedolce and many others

[pas_rescigno @PasRescigno]

We just closed the second edition of #IUCS24 great talks form @neerajaiims @montypal @alison_tree @giannatempopatr @DrYukselUrun @LauraMarandino but also time to meet friends! @FabrizioDiCost @emanuele_crupi @DanieleRaggi83 Big thank you to @gbanna74 for another amazing meeting

[Emanuele Crupi, MD @emanuele_crupi]

@PasqualeRes delivering an insightful presentation on #PCa at #IUCS24 in #Portsmouth, exploring the intricate micro and macro world of biomarkers.
Are we on the brink of utilizing composite biomarker signatures to tailor personalized treatments for our patients? @OncoAlert